Boston, MA -- (SBWIRE) -- 01/28/2013 -- Global Market Direct's pharmaceuticals report, "D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2012" provides data on the D. Western Therapeutics Institute, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, D. Western Therapeutics Institute, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from D. Western Therapeutics Institute, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- D. Western Therapeutics Institute, Inc. - Brief D. Western Therapeutics Institute, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of D. Western Therapeutics Institute, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of D. Western Therapeutics Institute, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the D. Western Therapeutics Institute, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get this Report

- Evaluate D. Western Therapeutics Institute, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of D. Western Therapeutics Institute, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the D. Western Therapeutics Institute, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with D. Western Therapeutics Institute, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of D. Western Therapeutics Institute, Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Cell Therapeutics, Inc. - Product Pipeline Review - 2012
- Carcinomas - Pipeline Review, H2 2012
- Diabetic Retinopathy - Pipeline Review, H1 2012
- Glioma - Pipeline Review, H2 2012
- Alzheimer's Disease - Pipeline Review, H1 2012
- Liver Diseases - Pipeline Review, H2 2012
- Small-Cell Lung Cancer - Pipeline Review, H1 2012
- Arthur G. James Cancer Hospital & Richard J. Solove Research Institute - Developmental Therapeutics Review - Q1 2011
- Esophageal Cancer - Pipeline Review, H2 2012
- Protozoal Infection - Pipeline Review, H2 2012